Stress echocardiography versus radionuclide stress techniques

The different modalities of stress echocardiography and stress thallium-201 imaging have comparable sensitivity, specificity, and overall predictive accuracy in the diagnosis and prognosis of coronary artery disease. They are also comparable in the assessment and follow-up of patients treated with thrombolytic therapy or who have undergone percutaneous transluminal coronary angioplasty and coronary artery bypass graft surgery. Stress radionuclide ventriculography has a lower sensitivity and specificity as compared to stress echocardiography and stress thallium. Dipyridamole thallium has a higher sensitivity as compared to dipyridamole echocardiography in the diagnosis and prognosis of coronary artery disease. New techniques such as dobutamine echocardiography, adenosine stress thallium-201, and adenosine echocardiography have individually shown high sensitivities, specificities, and accuracy. However, further studies are needed on their comparative value. The major advantages of stress echocardiography over radionuclide stress techniques are: lack of radiation exposure; less expense; less time consumption; less personnel required; and greater availability. Its major disadvantage, however, is the inability to obtain adequate studies in all patients.     

The noninvasive assessment of myocardial viability

The major objective of noninvasive imaging for detection of myocardial viability is to assist in the improved selection of patients with coronary artery disease and severe left ventricular dysfunction who would benefit most from revascularization. The techniques most commonly used to identify viable myocardium are thallium-201 (TI) scintigraphy, positron emission tomography (PET) using a flow tracer in combination with a metabolic tracer, technetium-99m (Tc) sestamibi imaging, and dobutamine echocardiography. On stress TI scintigraphy, asynergic regions showing normal thallium uptake, an initial defect with delayed redistribution at 3–4 h, late redistribution at 24 h, or defect reversibility after reinjection of a second dose of TI at rest all suggest preserved viability. The greater the final uptake of TI in areas of regional myocardial dysfunction preoperatively, the greater the improvement in ejection fraction after coronary revascularization. Demonstration of uptake of fluoro-18 deoxyglucose (FDG) in regions of diminished blood flow on PET imaging also correlates well with improved systolic function after revascularization. Tc sestamibi may also be useful for assessment of myocardial viability, particularly after thrombolytic therapy for acute myocardial infarction. Dobutamine echocardiography has good positive predictive value for viability determination, but absence of systolic thickening in an akinetic zone in response to intravenous infusion of the drug may still be associated with viable myocardium in 25–50% of segments. Of all the techniques cited above, quantitative resting TI scintigraphy may be the best approach for distinguishing between viable and irreversibly injured myocardium.     

Exercise echocardiography after stabilization of unstable angina: correlation with exercise thallium-201 single photon emission computed tomography.

The diagnostic usefulness of predischarge exercise echocardiography in 35 patients with unstable angina who responded to medical therapy was correlated with exercise thallium-201 single photon emission computed tomography (TI-SPECT) performed, on the average, three days after the exercise echocardiography. None of the patients had myocardial infarction prior to hospitalization or before TI-SPECT and none had left bundle-branch block on their rest electrocardiogram (ECG). Exercise echocardiography was positive in 21 patients and TI-SPECT in 24. The results of the two techniques were concordant in 28 of 35 patients (agreement = 80%, k = 0.57 +/- 0.14, p less than 0.001). Wall-by-wall comparison of the distribution of exercise-induced wall motion abnormalities with reversible thallium defects showed complete or partial correlation in all of 19 patients in whom both the tests were positive. A positive exercise ECG and positive exercise echocardiography identified 11 of 11 patients with angiographically verified significant coronary artery disease (CAD) and 11 of 12 patients (92%) with positive TI-SPECT. Thus, exercise echocardiography is a valuable addition to routine predischarge exercise test in the noninvasive diagnosis of myocardial ischemia and shows a good correlation with TI-SPECT in detecting and localizing ischemia in patients with unstable angina stabilized on medical therapy.     

Dobutamine stress echocardiography compared with dipyridamole thallium-201 single-photon emission computed tomography in detecting coronary artery disease

To compare the diagnostic value of dobutamine stress echocardiographywith dipyridamole thallium-201 single-photon emission computedtomography (SPECT) in detecting coronary artery disease (CAD),we performed both tests on 54 patients who also underwent coronaryarteriography. Dobutamine was infused at an incremental regimenof 5,10,20,30 and 40 µg. kg^-1. min^-1. Dipyridamole wasinfused at a rate of 0.14 mg. kg^-1. min^-1 over 4 min. Dobutaminestress echocardiography detected 40 (93%) and SPECT 42 (98%,P=ns) of the 43 patients with significant CAD, defined as (greaterthan or equal) 50% diameter stenosis. The specificity was 73%(8 of 11) for both tests. The sensitivity for detecting individualcoronary artery stenosis with dobutamine stress echocardiographywas 81% (30 of 37) for the left anterior descending artery,75% (24 of 32) for the right coronary artery, and 61% (17 of28) for the left circumflex artery. For SPECT it was 89%, 97%(P>0.05 vs dobutamine stress echocardiography) and 75%, respectively. Among the 97 stenotic coronary arteries, 17 had mild to moderatestenosis (50%-69% diameter stenosis) and 80 had severe stenosis($$70% diameter stenosis). With dobutamine stress echocardiography,53% of the arteries with mild to moderate stenosis were identifiedvs 78% of those with severe stenosis (P<0.05). With SPECT,the sensitivity was 82% (14 of 17) in mild to moderate stenosisand 89% (71 of 80) in severe stenosis (P=ns). No major sideeffects occurred during either test. Thus, both dobutamine stressand SPECT are highly sensitive for detection and localizationof CAD. However, the sensitivity of dobutamine stress is affectedby the level of stenosis severity.     

Assessment of viability after myocardial infarction Clinical relevance and methodological problems

In patients with myocardial infarction, the distinction between reversible and irreversible ventricular dysfunction has important clinical implications since dysfunctional but viable myocardium will resume contraction following revascularization. Various methods have been developed for the identification of potentially reversible myocardial dysfunction. Thallium reinjection, immediately after stress-redistribution imaging, may provide evidence of myocardial viability by demonstrating thallium uptake in regions with apparently irreversible defects. Hypoperfused, hypocontractile segments may recover function after revascularization, when exhibiting increased 18F-fluoro-deoxy-glucose uptake on positron emission tomography. Improved contractile function by selective beta₁ adrenergic stimulation with low dose dobutamine may also indicate the presence of viable tissue and predict subsequent improvement upon restoration of adequate flow. Finally, exercise-induced ST segment elevation on leads exploring a recent myocardial infarction has also been shown to indicate the presence of viable, potentially salvageable tissue.     

Myocardial viability estimation during the recovery phase of stress echocardiography after acute beta-blocker administration

BACKGROUND: Myocardial viability assessment in severely dysfunctional segments by dobutamine stress echocardiography (DSE) is less sensitive than nuclear scanning. AIM: To assess the additional value of using the recovery phase of DSE after acute beta-blocker administration for identifying viable myocardium. METHODS: The study included 49 consecutive patients with ejection fraction (LVEF)or=4 viable segments were considered viable. Coronary revascularization followed within 3 months in all patients. Radionuclide evaluation of LVEF was performed before and 12 months after revascularization. RESULTS: Viability with DISA-SPECT was detected in 463 (59%) segments, while 154 (19.7%) segments presented as scar. The number of viable segments increased from 415 (53%) at DSE to 463 (59%) at DSE and recovery, and the number of viable patients increased from 43 to 49 respectively. LVEF improved by >or=5% in 27 patients. Multivariate regression analysis showed that, DSE with recovery phase was the only independent predictor of >or=5% LVEF improvement after revascularization (OR 14.6, CI 1.4-133.7). CONCLUSION: In this study, we demonstrate that the recovery phase of DSE has an increased sensitivity for viability estimation compared to low-high dose DSE.     

Myocardial ischemia due to vasospasm of small coronary arteries detected by methylergometrine maleate stress myocardial scintigraphy

BACKGROUND: Recently, several case reports have implicated vasospasm of small coronary arteries in vasospastic angina pectoris. Vasospasm of small coronary arteries was also considered from angiographic findings in patients with atypical chest pain. In Syrian hamster, vasospasm in small coronary arteries was considered to be the cause of dilated cardiomyopathy. HYPOTHESIS: This study was undertaken to determine whether vasospasm in small coronary arteries can be induced by methylergometrine maleate stress thallium-201 (201Tl) myocardial scintigraphy. METHODS: Twenty-five patients with chest pain, all of whom had intact coronary arteries, were studied. After intracoronary methylergometrine maleate injection, coronary arteriograms also looked normal in all cases. Thallium-201 myocardial scintigraphy was carried out immediately after intracoronary methylergometrine maleate injection in four patients with chest pain. In the remaining 21 patients with chest pain, methylergometrine maleate was given intravenously within up to 2 weeks before 201Tl myocardial scintigraphy. RESULTS: In the intracoronary injection study, one patient had chest discomfort after methylergometrine maleate injection, and ST-segment elevation was observed on electrocardiogram (ECG). Of the 21 patients with chest pain, 11 patients felt angina-like chest pain after intravenous injection of methylergometrine maleate, but their ECGs showed no ischemic changes. Stress 201Tl myocardial scintigrams showed methylergometrine maleate-induced perfusion defects with complete redistribution in 3 of 4 patients in the intracoronary injection study and in 12 of 21 patients in the intravenous injection study. These findings suggest that vasospasm in small coronary arteries caused myocardial ischemia in 15 of 25 patients (60%) with chest pain. CONCLUSION: Vasospasm in small coronary arteries may be involved in the myocardial ischemia of some patients with chest pain who do not show any large coronary artery vasospasm.     

Early postexercise thallium-201 reinjection after sublingual nitroglycerin augmentation: Effects on detection of myocardial ischemia and/or viability

Background: Thallium-201 (²⁰¹Tl) reinjection after conventional redistribution imaging is a standard procedure, resulting in enhanced ²⁰¹ Tl redistribution which is compatible with viable myocardium. Although this method significantly improves identification of viable myocardium, it increases the investigation time by approximately 1 h. Thus, this technique is suboptimal from the standpoint of patient convenience, since its routine performance may be impractical in a high-volume nuclear medicine laboratory. Hypothesis: This study was undertaken to evaluate the efficacy of an early ²⁰¹Tl reinjection and imaging protocol in combination with sublingual nitroglycerin, to detect myocardial ischemia and/or viability, and to reduce the need for conventional (4 h) redistribution imaging. Materials and Methods: In this study, 62 consecutive coronary patients, referred for the detection of possible myocardial ischemia and/or viability, were involved (mean age 55 years, range 41-70). Of those, 50 had previous angina attacks, with 42 having a history of previous myocardial infarction; 10 patients had coronary artery bypass grafting; and the remaining 2 had atypical chest pain. Immediately after the completion of the initial postexer-cise imaging, 0.3 mg sublingual nitroglycerin followed by the reinjection of 1 m Ci of ²⁰¹Tl were administered, and two further sets of images were acquired 1 h and 4h later. Results: In each set of i mages, a total of496 segments were analyzed. On postexercise imaging, 305 (61%) segments demonstrated defects of which 198 (65%) showed enhanced thallium uptake, 97 (32%) did not change, and 10(3%) showed reverse redistribution on 1 h reinjection imaging (IRI). Of the 97 persistent defects, only 17 (6%) showed fill-in of ²⁰¹ Tl on 4 h redistribution imaging (CRI), while 12 (4%) segments showed reverse redistribution. On the other hand, after analyzing the 62 patients of the 1 h IRI, 17 (27%) remained unchanged while in only 1 patient (6%) of 17 the diagnosis changed from myocardial necrosis to ischemia after analysis ofthe 4h CRI. Conclusion: These results indicate that early postexercise reinjection of ²⁰¹Tl in combination with sublingual nitroglycerin followed by l h image acquisition may prove useful for a comprehensive and convenient assessment of myocardial ischemia and/or viability.     

Pulsed Tissue Doppler Imaging to Assess Myocardial Viability by Quantification of Regional Myocardial Functional Reserve

Dobutamine stress echocardiography (DSE) is used widely to evaluate myocardial viability, but is limited by the subjective nature of test interpretation. Assessment of systolic function by pulsed tissue Doppler imaging (TDI) during dobutamine stimulation may allow a more objective evaluation of myocardial functional reserve and, thus, myocardial viability. In 30 patients (58 +/- 9 years) with prior myocardial infarction, pulsed TDI with low dose dobutamine stress (10 microg/kg/min) was performed to assess myocardial viability. Qualitative assessment of two-dimensional (2-D) DSE and positron emission tomography (PET) were used for comparison. Peak systolic myocardial velocity was measured for each left ventricular segment (16 segments) at baseline and low dose dobutamine stress using pulsed TDI. The absolute and relative increases of peak systolic velocity from rest to low dose dobutamine stress were calculated. Three hundred sixty-four segments with adequate pulsed TDI tracing were divided according to either 2-D DSE or PET findings into normal, viable (mismatch), and nonviable (match) segments. The increase of peak systolic myocardial velocity from baseline to low dose dobutamine was significantly different between segments defined as normal, viable, and nonviable by 2-D DSE (2.71 +/- 1.91 cm/sec, 1.86 +/- 2.15 cm/sec, and 0.99 +/- 1.16 cm/sec, respectively; P < 0.001). The increase of peak systolic myocardial velocity from rest to low dose dobutamine for normal, mismatch, and match segments defined by PET was 2.72 +/- 1.96, 1.01 +/- 0.96 and 0.80 +/- 1.07 cm/sec, respectively (P < 0.001). In conclusion, the increase of peak systolic myocardial velocity during low dose dobutamine stimulation determined by pulsed TDI distinguishes between different myocardial viability states. It complements the standard interpretation of stress echocardiograms.     

Myocardial perfusion imaging with positron emission tomography and single photon emission computed tomography: frequency and causes of disparate results

The purpose of this study was to compare rubidium-82 PET withthallium-201 SPECT imaging in 150 patients. Both techniquesfollowed a single dipyridamole-handgrip stress, and images weredisplayed using the same 3-dimensional format and quantitativecolour scale. Coronary arteriography was employed to assignthe correct diagnosis in situations of disparity. Results of PET and SPECT were at least partially concordantin 110 patients (73%), although 22 had more than one defect.A reversible perfusion defect was identified in 60 patients,but the scans were concordant in only 20 (33%). These disparitieswere chiefly due to false-negative SPECT imaging (22 patients,55%), and probable delayed thallium redistri bution (13 patients,33%). No patients had ischaemia correctly identified by SPECTin the presence of normal PET imaging. Persistent defects wereidentified in 91 patients, some of whom also had reversibledefects, and the results were consistent in 54 (59%). Otherthan the delayed thallium redistribution group, the major categoriescausing disparities were false-positive (6 patients, 16%), andfalse negative SPECT (8 patients, 22%), attributable to attenuationand scatter. PET appears able to identify smaller, less ischaemic areas subtendedby milder coronary stenoses. The availability of a true restingscan with Rb-PET enhances the discrimination between ischaemiaand infarction. Attenuation correction, and the high energyphotons of positron annihilation, yield more accurate evaluationof inferior wall defects and greater specificity in the presenceof soft tissue attenuation.     

Myocardial perfusion imaging with positron emission tomography and single photon emission computed tomography: frequency and causes of disparate results.

The purpose of this study was to compare rubidium-82 PET with thallium-201 SPECT imaging in 150 patients. Both techniques followed a single dipyridamole-handgrip stress, and images were displayed using the same 3-dimensional format and quantitative colour scale. Coronary arteriography was employed to assign the correct diagnosis in situations of disparity. Results of PET and SPECT were at least partially concordant in 110 patients (73%), although 22 had more than one defect. A reversible perfusion defect was identified in 60 patients, but the scans were concordant in only 20 (33%). These disparities were chiefly due to false-negative SPECT imaging (22 patients, 55%), and probable delayed thallium redistribution (13 patients, 33%). No patients had ischaemia correctly identified by SPECT in the presence of normal PET imaging. Persistent defects were identified in 91 patients, some of whom also had reversible defects, and the results were consistent in 54 (59%). Other than the delayed thallium redistribution group, the major categories causing disparities were false-positive (6 patients, 16%), and false negative SPECT (8 patients, 22%), attributable to attenuation and scatter. PET appears able to identify smaller, less ischaemic areas subtended by milder coronary stenoses. The availability of a true resting scan with Rb-PET enhances the discrimination between ischaemia and infarction. Attenuation correction, and the high energy photons of positron annihilation, yield more accurate evaluation of inferior wall defects and greater specificity in the presence of soft tissue attenuation.     

Routinary PET/CT imaging for oncological surveillance accompanied by echocardiography may identify early atherosclerotic cardiovascular disease: A case report

Atherosclerosis is a disease where plaque builds up in arteries, resulting in harmful cardiovascular events. Inflammation has a significant role in its progression, starting from the initial stages. Cancer patients, due to their constant exposure to inflammatory processes caused by treatments or illnesses, are at a higher risk of developing this condition. Arterial inflammation can be quantified with ¹⁸F-FDG PET/CT imaging. In this case report, we propose that routinary PET/CT imaging for oncological surveillance could be useful for cardiovascular risk stratification by reviewing a case of a patient with breast cancer whose imaging study revealed arterial inflammation and a subsequent echocardiogram evidenced grade II diastolic dysfunction (potentially, an initial manifestation of the ischemic cascade).     

Current therapy in cardiovascular disease 1984–1985: Editor: Nicholas J. Fortuin B.C. Decker,Ontario/Philadelphia,and The C.V. Mosby Co., St. Louis,Toronto, 1984; 410 pp.; £46.00; ISBN 0-941158-27-6

We describe a case of myocardial bridging of the anterior descending coronary artery associated with a non-obstructive hypertrophic cardiomyopathy which was corrected by surgery because of a poor response to standard drug therapy. The clinical significance of the association is discussed. The possibility of repair by surgery should be considered when an area of ischemia supplied by the affected vessel is detected and previous medical treatment has been ineffective.     

Viable Myocardium: How Much Is Enough?

Left ventricular systolic dysfunction is mainly a result of coronary artery disease (CAD). Decrease in myocardial contractility results as a response to a chronic hypoperfusion state that produces a change in cardiac myocyte metabolism, resulting in a perfusion-contraction mismatch in which function is sacrificed for survival. If revascularization is performed in a timely fashion, metabolism can be restored leading to recovery of function. Through the use of noninvasive imaging modalities, assessing myocardial viability can be easily performed and will aid in selecting those patients who will benefit from revascularization. Viable myocardium can be identified by nuclear modalities that have a high sensitivity but a lower specificity, such as thallium-201 single photon emission computed tomography and positron emission tomography (PET); or by the use of dobutamine stress echocardiogram (DSE), which has a decreased sensitivity but a better specificity. A modality that is increasingly being used with an overall good sensitivity and specificity is contrast-enhanced magnetic resonance imaging. The purpose of this review is to explore the amount of myocardial viability that is relevant to pursue revascularization, since as myocardial function improves there is a decrease in morbidity and mortality from heart failure and arrhythmias.     

Use of dobutamine stress echocardiography in detecting silent myocardial ischaemia in asymptomatic diabetic patients: a comparison with thallium scintigraphy and exercise testing.

AIMS: Silent myocardial ischaemia is frequent in diabetic patients. The aim of this study was to compare the efficacy of thallium-201 single-photon emission computed tomography (201Tl SPECT) coupled with exercise stress testing (EST), and dobutamine stress echocardiography (DSE) in the detection of asymptomatic coronary artery disease. METHODS: Fifty-six asymptomatic diabetic patients, with a known duration of diabetes > 15 years for Type 1 and > 5 years for Type 2, having at least three added risk factors, but without rest ECG abnormalities, were enrolled in this prospective study. All of them were submitted to DSE with a maximum infusion rate of 40 microg/kg per min dobutamine +/- i.v. atropine, and to 201Tl SPECT coupled with EST. Coronary angiography was performed if at least one test was abnormal. RESULTS: Diabetic patients were 37 males and 19 females, aged mean (sd) 60 +/- 10 years, 10 Type 1 and 46 Type 2, with a known duration of disease of mean (sd) 17 +/- 9 years. Feasibility of DSE was 91%. No serious complication occurred during the test. Coronary angiography was performed in 26 patients (47%); 17 were abnormal (30% of the whole group): six patients had a one-vessel, six a two-vessel and five a three-vessel disease. Predictive positive value was 69% for DSE, 75% for 201Tl SPECT and 60% for EST. DSE was falsely negative in four cases vs. eight for 201Tl SPECT and nine for EST. CONCLUSIONS: Asymptomatic coronary disease is common in diabetes associated with other risk factors. DSE appears useful in its detection and a good alternative to 201Tl SPECT.     

Bayesian analysis of stress thallium scintigraphy for the detection of multivessel coronary disease

This study was performed in 224 men to determine the respectivecontribution of history and thallium-201 stress myocardial scintigraphicimaging in the non-invasive prediction of the severity of coronarydisease. Myocardial scintigraphic imaging had the better diagnostic accuracy(80%) for the detection of multivessel disease but the resultsemphasize the importance of the history in predicting the extentof coronary artery disease. In patients with myocardial infarction, the diagnostic accuracyof the history (80%) was similar to the diagnostic accuracyof myocardial scintigraphic imaging (79%), in the subgroup ofpatients with residual angina pectoris after infarction, theaccuracy of the history was even greater (87%) than that ofmyocardial scintigraphic imaging (78%). Thus, after myocardialinfarction, scintigraphy was useful only in the small subgroupof patients without residual angina pectoris when it had a diagnosticaccuracy of 79%, slightly but insignificantly superior to thatof the history (62%). In patients without previous myocardialinfarction, but with typical angina, myocardial scintigraphywas clearly superior to the simple history (diagnostic accuracyof 78% versus 53%; P < 0.001). In patients without myocardialinfarction and with atypical angina the prevalence of multivesseldisease was low (17%) and the diagnostic accuracy of history(83%) was barely different from the diagnostic accuracy of myocardialscintigraphic imaging (90%). Thus, when the likelihood of multivesseldisease is very high (angina pectoris post myocardial infarction),or very low (atypical angina), the contribution of exercisetesting is very limited. Important additional information isprovided by maximal exercise testing and myocardial scintigraphicimaging only in the groups with an intermediate prevalence ofmultivessel disease, namely in the asymptomatic patients aftermyocardial infarction and in the patients with typical anginabut no previous myocardial infarction.     

Current status of stress echocardiography

Stress echocardiography is a widely applied technique for the evaluation of individuals with known or suspected coronary artery disease. The technique combines echocardiographic imaging with exercise testing or pharmacologic stress. Advances in digital image acquisition and harmonic imaging have substantially improved the quality of echocardiographic images, and have therefore increased general applicability of stress echocardiography.     

Myocardial bridging of the left anterior descending artery: Evaluation using exercise thallium-201 myocardial scintigraphy

Seven patients with myocardial bridging of the left anterior descending coronary artery were evaluated by means of thallium-201 exercise scintigraphy. The degree of systolic narrowing was 60–70% in five patients and 75–80% in two patients. All patients had presented with chest pain. The resting electrocardiogram was normal in six patients; there were ST segment and T-wave abnormalities in one patient. No patient complained of chest pain during exercise. The exercise electrocardiogram was negative in six patients and inconclusive in one patient. Exercise myocardial scans were negative in all seven patients. We conclude that no evidence of ischemia was demonstrated in patients with myocardial bridging of the left anterior descending coronary artery as determined by exercise electrocardiography and stress thallium-201 scintigraphy.     

Myocardial viability after primary coronary angioplasty: low-dose dobutamine stress echocardiography versus myocardial contrast echocardiography.

BACKGROUND: Successful reperfusion therapy in patients with acute myocardial infarction (AMI) improves survival. Indeed, after AMI myocardial dysfunction may be reversible (hibernating or stunned myocardium). Low-dose dobutamine stress echocardiography (LDDSE) provides us with the possibility of evaluating viable myocardial segments, while myocardial contrast echocardiography (MCE) allows the study of the microcirculation in the same myocardial areas. The aim of our study was to compare LDDSE and MCE, in the prediction of the recovery of segments in patients with AMI who were submitted to primary coronary angioplasty (PTCA). METHODS: We studied 14 patients with AMI. Both LDDSE and MCE with Levovist were performed after primary PTCA. The viability gold standard was a recovery of contractility detected at echocardiography 2 months later. RESULTS: For LDDSE, the sensitivity was 91%, the specificity 71% and the positive and negative predictive values were 93 and 64% respectively. For MCE, the sensitivity was 94%, the specificity 44%, the positive predictive value 89%, and the negative predictive value 59%. Two tests agreed in 81% of the cases. Stress echocardiography and contrast echocardiography agreed in 81% of cases. CONCLUSIONS: LDDSE has a very good positive accuracy, it has an acceptable negative predictive value and is relatively cheap. On the other hand, MCE has a good positive accuracy, but a low negative accuracy and carries a high cost. The integration of these two tests, which are too expensive in clinical practice, could improve our comprehension of the post-PTCA pathophysiology.     

Comparative prognostic significance of transesophageal versus transthoracic stress echocardiography

Patients with a negative transthoracic stress echocardiographic study (TTE-SE) are at low risk for adverse cardiac events. Because of a higher sensitivity for detection of coronary artery disease, transesophageal dobutamine stress echocardiography (TEE-DSE) might permit identification of an even lower risk population. We compared the relative prognostic values of TTE-SE and TEE-DSE in 236 patients with negative stress echocardiograms. Baseline and follow-up information on 236 consecutive subjects who had a negative stress echocardiographic study during the period of October 1996 to December 1997 was obtained. Baseline cardiac risk factors and major cardiac events (nonfatal myocardial infarct or cardiac death) were identified. Follow-up was obtained in 233 subjects for a mean duration of 25 months. At baseline, the TEE-DSE group had more hypertensives (85% vs 67%, P = 0.02) and more baseline wall-motion abnormalities (41% vs 26%, P = 0.03). At 34 months of follow-up, there was no significant difference in the occurrence of major cardiac events between the two groups (8% vs 8.6%, P = NS). In the TEE-DSE group, there were more than twice as many events in the second year of follow-up as compared with the first year, indicating that a negative TEE-DSE has lessened prognostic value 1 year after the test. Standard TTE-SE provides prognostic data in patients at high risk for major cardiac ischemic events that is equivalent to that obtained by TEE-DSE. While advances in ultrasound techniques may improve our ability to detect coronary artery disease, it remains to be seen whether this will have an impact on prognostication.